-+ 0.00%
-+ 0.00%
-+ 0.00%
Valion Bio says IACUC clears AFRRI-run Entolimod radiation-injury study in mice
Share
Listen to the news
Valion Bio says IACUC clears AFRRI-run Entolimod radiation-injury study in mice
  • Valion Bio disclosed a U.S. government-funded AFRRI/NIAID program evaluating Entolimod for lethal radiation-induced gastrointestinal injury.
  • IACUC approval secured for the AFRRI mouse studies; a safety study is set to start this week.
  • Therapeutic study to follow, with top-line data expected in early fall.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending